exRNAdisease

Entry Detail

---



General Information

Database ID: exR0093346 RNA Name: hsa-miR-27a-3p RNA Type: miRNA Chromosome: chr19 Starnd: - Coordinate: Start Site(bp): 13836447 End Site(bp): 13836467 External Links: hsa-miR-27a-3p

Disease Information

Disease Name: Benign Ovarian Disease Disease Category: Urogenital Diseases and Pregnancy Complications MeSH ID: D010049 Type: Diseases Category/Female Urogenital Diseases and Pregnancy Complications Alias: Ovarian Diseases//Disease, Ovarian//Diseases, Ovarian//Ovarian Disease

Expression Detail

GEO ID: GSE106817 Description: Integrated extracellular microRNA profiling for ovarian cancer screening Experimental Design: Cancer vs Control Case Disease Type: Benign Ovarian Disease Case Disease SubType: NA Case Sample: Benign Ovarian Disease Control Sample: Non-Cancer Number of Case: 29 Number of Control: 2759 Number of Samples: 2788

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand IGF2BP3 chr7 23310209 23470491 - SOX11 chr2 5692384 5701385 + AEN chr15 88621337 88632281 + SUCO chr1 172532349 172611833 + ALDH3A2 chr17 19648136 19685760 + CD2AP chr6 47477789 47627263 + TTYH3 chr7 2631986 2664802 + C1orf116 chr1 207018522 207032756 - GLTP chr12 109850945 109880541 - PAX9 chr14 36657568 36679362 + TMEM30A chr6 75252924 75284948 - NUAK1 chr12 106063340 106140033 - LGALS8 chr1 236518000 236552981 + ACER3 chr11 76860867 77026797 + NEK2 chr1 211658657 211675630 - CDR2 chr16 22345936 22437165 - B4GALT3 chr1 161171310 161177968 - JRK chr8 142657460 142681968 - KCNK1 chr1 233614106 233672514 + ACLY chr17 41866917 41930542 - TMX4 chr20 7977346 8019805 - PPP1CC chr12 110719680 110742939 - KPNA6 chr1 32108056 32176563 + HTT chr4 3041422 3243960 + NF1 chr17 31094927 31382116 + ETNK1 chr12 22625075 22690665 + ZBTB34 chr9 126860665 126885878 + CANX chr5 179678628 179731641 + PAK1 chr11 77321707 77474635 - GIPC1 chr19 14477760 14496149 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000384 chr12 27867712 27877119 + hsa_circ_0001247 chr22 46125304 46136418 + hsa_circ_0000942 chr19 46020920 46021352 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC010980.2 chr2 222317242 222318653 - AC021092.1 chr19 44103007 44113183 - AC022150.4 chr19 52650437 52653284 - AC093010.3 chr3 114314501 114329714 - AL050341.2 chr1 40256427 40257967 - KCNQ1OT1 chr11 2608328 2699994 - LINC01089 chr12 121795267 121803906 - LINC02381 chr12 54126082 54147485 + NEAT1 chr11 65422774 65445540 + SDCBP2-AS1 chr20 1325405 1378735 + SNHG22 chr18 49814023 49851059 + TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE106817 Sample Source: Blood Source Fraction: Serum Platform: GPL21263 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2535 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.). RNA library preparation protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

Reference

PMID: 30333487 Title: Integrated extracellular microRNA profiling for ovarian cancer screening Author: Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T Journal: Nat Commun. 2018 Oct 17;9(1):4319. Description: to develop an optimal detection method, we use microarrays to obtain comprehensive miRNA profiles from 4046 serum samples, including 428 patients with ovarian tumors.